TrialClinical pharmacokinetics2021

Effect of Kidney or Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Somapacitan: Two Open-Label, Parallel-Group Trials.

Birgitte Bentz Damholt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.